<DOC>
	<DOC>NCT00667758</DOC>
	<brief_summary>The purpose of this study is to compare the safety and efficacy of gonadotropin-releasing hormone (GnRH) antagonist therapy versus placebo in patients with moderate to severe rheumatoid arthritis.</brief_summary>
	<brief_title>Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Adult between 18 years and above Moderate to severe disease activity Negative pregnancy test for women of childbearing potential Use of reliable method of contraception (nonhormonal) by sexually active female patients Patients who are pregnant or breastfeeding Patients taking biologic therapy or prednisolone &gt;7.5mg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>